Clinical trial
Parkinson's Disease Treatment With Coenzyme Q10
NCT00004731 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00004731 |
|---|---|
| Title | Parkinson's Disease Treatment With Coenzyme Q10 |
| Official title | Effects of Coenzyme Q10 in Early Parkinson's Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Coenzyme Q10 |
| Start date | Sep 1, 1998 |
| Completion | Oct 1, 2003 |
| First posted | Feb 28, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: